An immunosuppressive triumvirate to minimize renal injuries associated with calcineurin antagonist therapy.
Kahan
B D
BD
The University of Texas Medical School, Department of Surgery, Houston 77030, USA.
D019703:Calcineurin / Q000009:adverse effects; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D051437:Renal Insufficiency / Q000139:chemically induced*; D016559:Tacrolimus / Q000627:therapeutic use*; D014666:Vasomotor System / Q000187:drug effects
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019703:Calcineurin; D016559:Tacrolimus